InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
15
T+90 hit rate
25%
T+90 mean return
-3.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Congleton Jon, Chief Executive Officer. Insider active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 21 reports have been recorded. Breakdown: 4 buys · 15 sells. Total volume traded: €3.7m. History available since 11 August 2023. The latest transaction was disclosed on 13 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Congleton Jon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
10,700 shares@ US$27.23750.010% mcap4.5% of flowCommon StockSEC:0001933414-26-000100:0
58,000 sharesCommon StockSEC:0001933414-26-000096:0
17,000 sharesCommon StockSEC:0001933414-26-000096:1
15,730 shares@ US$26.82640.016% mcap11.7% of flowCommon StockSEC:0001933414-26-000075:0
19,364 shares@ US$25.50060.019% mcap13.9% of flowCommon StockSEC:0001644975-26-000004:0
140,900 shares0Common StockSEC:0001933414-26-000045:0
9,119 shares@ US$32.20830.011% mcap8.2% of flowCommon StockSEC:0001644975-26-000002:0
24,082 shares@ US$0.540.3% of flowCommon StockSEC:0001644975-25-000006:0
12,806 shares@ US$41.639513.6% of flowCommon StockSEC:0001933414-25-000151:0
13,548 shares@ US$42.62950.022% mcap16.2% of flowCommon StockSEC:0001933414-25-000129:0
15,884 shares@ US$14.50716.7% of flowCommon StockSEC:0001933414-25-000078:0
15,319 shares@ US$12.19423.9% of flowCommon StockSEC:0001933414-25-000044:0
18,333 shares@ US$9.05923.8% of flowCommon StockSEC:0001933414-25-000003:0
15,271 shares@ US$13.5184.4% of flowCommon StockSEC:0001933414-24-000045:0
15,746 shares@ US$13.34154.5% of flowCommon StockSEC:0001933414-24-000033:0
17,766 shares@ US$12.25444.7% of flowCommon StockSEC:0001933414-24-000032:0
16,607 shares@ US$12.76654.6% of flowCommon StockSEC:0001933414-24-000029:0
4,250 shares@ US$5.96610.5% of flowCommon StockSEC:0001933414-23-000093:0
Canonical exit: 20 Feb 2024 (T+90)
2,250 shares@ US$12.080.6% of flowCommon StockSEC:0001933414-23-000067:0
Canonical exit: 5 Dec 2023 (T+90)
2,250 shares@ US$12.100.6% of flowCommon StockSEC:0001933414-23-000065:0
Canonical exit: 15 Nov 2023 (T+90)
2,000 shares@ US$12.890.5% of flowCommon StockSEC:0001933414-23-000061:0
Canonical exit: 9 Nov 2023 (T+90)
21 of 21 declarations
About Congleton Jon
Congleton Jon is Chief Executive Officer at Mineralys Therapeutics, Inc. He has 21 filings, and across the sampled recent filings from 2023-08-11 to 2026-07-15, the aggregated amounts show EUR 97,079 of purchases and EUR 3,560,013 of sales, with disposal being the most frequent transaction type.
